Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 31% ± 17% | |
lung | 10 studies | 24% ± 9% | |
peripheral blood | 9 studies | 22% ± 6% | |
adipose | 4 studies | 18% ± 2% | |
eye | 3 studies | 25% ± 7% | |
heart | 3 studies | 20% ± 2% | |
uterus | 3 studies | 28% ± 12% | |
liver | 3 studies | 38% ± 16% | |
intestine | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2875.07 | 459 / 459 | 100% | 45.08 | 1118 / 1118 |
esophagus | 100% | 2540.67 | 1445 / 1445 | 100% | 31.45 | 183 / 183 |
lung | 100% | 3278.13 | 578 / 578 | 100% | 30.60 | 1155 / 1155 |
ovary | 100% | 3522.55 | 180 / 180 | 100% | 33.90 | 430 / 430 |
prostate | 100% | 2555.68 | 245 / 245 | 100% | 33.92 | 502 / 502 |
brain | 100% | 2184.40 | 2639 / 2642 | 100% | 31.76 | 705 / 705 |
uterus | 100% | 3021.44 | 170 / 170 | 100% | 34.72 | 457 / 459 |
thymus | 100% | 2936.26 | 653 / 653 | 100% | 37.54 | 602 / 605 |
liver | 100% | 3033.26 | 226 / 226 | 99% | 28.69 | 403 / 406 |
kidney | 100% | 1854.03 | 89 / 89 | 99% | 24.26 | 892 / 901 |
bladder | 100% | 2688.57 | 21 / 21 | 99% | 33.05 | 498 / 504 |
adrenal gland | 100% | 3259.48 | 258 / 258 | 99% | 22.20 | 227 / 230 |
pancreas | 100% | 1352.85 | 327 / 328 | 99% | 27.46 | 176 / 178 |
stomach | 100% | 1973.66 | 359 / 359 | 98% | 30.57 | 279 / 286 |
intestine | 100% | 2712.02 | 966 / 966 | 97% | 31.31 | 512 / 527 |
skin | 100% | 2646.59 | 1806 / 1809 | 96% | 40.25 | 454 / 472 |
adipose | 100% | 3139.76 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2724.30 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.03 | 29 / 29 |
muscle | 100% | 3009.02 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2660.35 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.82 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.04 | 1 / 1 |
heart | 99% | 2232.95 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 2974.43 | 864 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 16.30 | 69 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010569 | Biological process | regulation of double-strand break repair via homologous recombination |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0036211 | Biological process | protein modification process |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0030289 | Cellular component | protein phosphatase 4 complex |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP4R2 |
Protein name | Serine/threonine-protein phosphatase 4 regulatory subunit 2 Protein phosphatase 4 regulatory subunit 2 HCG14948, isoform CRA_a (Protein phosphatase 4 regulatory subunit 2) |
Synonyms | SBBI57 hCG_14948 |
Description | FUNCTION: Regulatory subunit of serine/threonine-protein phosphatase 4 (PP4). May regulate the activity of PPP4C at centrosomal microtubule organizing centers. Its interaction with the SMN complex leads to enhance the temporal localization of snRNPs, suggesting a role of PPP4C in maturation of spliceosomal snRNPs. The PPP4C-PPP4R2-PPP4R3A PP4 complex specifically dephosphorylates H2AX phosphorylated on 'Ser-140' (gamma-H2AX) generated during DNA replication and required for DNA double strand break repair. Mediates RPA2 dephosphorylation by recruiting PPP4C to RPA2 in a DNA damage-dependent manner. RPA2 dephosphorylation is required for the efficient RPA2-mediated recruitment of RAD51 to chromatin following double strand breaks, an essential step for DNA repair. . |
Accessions | Q9NY27 ENST00000482242.5 A0AA34QVI2 H7C559 C9IZF4 ENST00000495566.1 F8WDK3 ENST00000476505.2 ENST00000710398.1 C9IZ04 F8WCA1 ENST00000356692.10 [Q9NY27-1] ENST00000460360.1 ENST00000488810.5 |